A non-invasive route of peptide administration via nasal spray. Allows some peptides to bypass the blood-brain barrier through the olfactory epithelium. Bioavailability varies widely (2-30%) depending on the peptide and formulation.
"Intranasal Delivery" is filed under Administration in the PeptideAtlas glossary, alongside 15 other terms in that group.
1 other glossary entry refer to this term in their own definition, which is usually the fastest way to see how it is used in practice.
A selective permeability barrier formed by tightly joined endothelial cells lining brain capillaries. Prevents most peptides from reaching brain tissue. Intranasal delivery, lipophilic modifications, or small peptide size can help bypass the BBB.
An injection administered into the fatty tissue layer between the skin and muscle. The most common route for peptide self-administration.
An injection administered directly into a muscle. Some peptides may be administered via IM injection under medical supervision.
Administration directly into a vein. Provides 100% bioavailability but requires medical supervision and sterile technique.
Terms that reference this one: Blood-Brain Barrier (BBB).
More Administration terms: Subcutaneous (SubQ), Intramuscular (IM), Intravenous (IV), Intranasal, Sublingual, Topical Peptide, Transdermal, Microneedle Patch, Insulin Syringe, Titration, Loading Dose, Maintenance Dose, Peptide Stack, Lipohypertrophy, Injection Site Rotation.